Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828994 · ClinicalTrials.gov registry record · NA
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
A NA study of Pelvic Inflammatory Disease, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03828994: Active NA study of Pelvic Inflammatory Disease, sponsored by Johns Hopkins University.
NCT03828994 is a NA study of Pelvic Inflammatory Disease that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 150 participants, roughly in line with the 137-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03828994, a NA study of Pelvic Inflammatory Disease, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) will receive additional testing and treatment in the field. The investigators hypothesize that repackaging the recommended Centers for Disease Control and Prevention (CDC) follow-up visit using a technology-enhanced community health nursing intervention (TECH-N) with integration of an evidence-based sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost-effective compared with outpatient standard of care (and hospitalization).
Primary Outcome
Trichomonas infection assessed with Aptima vaginal swab, tested using the Gen-Probe transcription mediated amplification (TMA) research assay.
Conditions Studied
Interventions
- BEHAVIORAL Tech-PN
Study Locations (1)
Maryland
- Johns Hopkins School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-02-10 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What the registry record for NCT03828994 still lists
NCT03828994 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 137-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target.
The record links to 1 condition, with Pelvic Inflammatory Disease appearing as the primary indexed condition, and to 1 intervention - of which Tech-PN is the first listed.
NCT03828994 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03828994 about?
NCT03828994 is a clinical study titled "Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II". The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) w...
What is the current status of trial NCT03828994?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2019-02-10. Estimated completion is 2027-03-31.
What conditions does trial NCT03828994 study?
This clinical trial studies the following conditions: Pelvic Inflammatory Disease.
What interventions are being tested in trial NCT03828994?
The interventions under investigation include: Tech-PN (BEHAVIORAL).
Who is sponsoring clinical trial NCT03828994?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03828994 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Inflammatory Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
COMPLETED · NA
-
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI